Non-ABO red cell antibodies and risk of COVID-19. (July 2021)

• Record Type: Journal Article
• Authors: Ray, Joel G.; Colacci, Michael; Schull, Michael J.; Vermeulen, Marian J.; Park, Alison L.
• Is Part Of: International journal of infectious diseases. Volume 108(2021)
• Page Start: 179
• Page End: 182
• Publication Date: 2021-07
• Subjects: SARS-CoV-2 -- COVD-19 -- ABO blood group -- Non-ABO blood group antibodies; Communicable diseases -- Periodicals; Communicable Diseases -- Periodicals; Communicable diseases; Periodicals; Electronic journals; 616.9
• DOI: 10.1016/j.ijid.2021.05.038
• Languages: English
• ISSNs: 1201-9712

Abstract

Abstract: It is not known whether non-ABO antibodies confer any protective effect against SARS-CoV-2 infection or COVID-19 severe illness alone or in conjunction with O blood group. This cohort study included 413 576 persons in Ontario, Canada with known ABO blood group and non-ABO antibody screen status, who subsequently underwent SARS-CoV-2 viral RNA polymerase chain reaction testing between January and November 2020. The risk of SARS-CoV-2 infection or COVID-19 severe illness was not associated with the presence of non-ABO antibodies, even among persons with O blood group.